---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-115578"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:42:34.097140+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cencora to acquire Retina Consultants of America for $4.6B, ~85% ownership, accretive $0.35

## Summary
- Enterprise value of $4.6B cash; expected cash outlay ~$4.3B after physician/management rollover and fees.
- Cencora will hold ~85% ownership; up to $500M contingent consideration in FY2027-2028 tied to predefined objectives.
- Transaction expected ~$0.35 accretive to adjusted diluted EPS in first 12 months post-close.
- RCA operates nearly 300 retina specialists across 23 states, 2M+ annual visits, 40 clinical trial sites.
- Funding via cash on hand and new debt; $3.3B bridge financing obtained; fiscal 2025 guidance excludes deal.

## SEC filing metadata
- accession: 0001104659-24-115578
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000110465924115578/0001104659-24-115578-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000110465924115578/tm2427560d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-115578
- JSON: https://secwatch.observer/filing/0001104659-24-115578.json
- Plain text: https://secwatch.observer/filing/0001104659-24-115578.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.